About the Authors
- Mikael Bjursell
-
* E-mail: mikael.bjursell@astrazeneca.com
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Marianne Wedin
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Therése Admyre
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Majlis Hermansson
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Gerhard Böttcher
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Melker Göransson
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Daniel Lindén
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Krister Bamberg
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Jan Oscarsson
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
- Mohammad Bohlooly-Y
-
Affiliation AstraZeneca R&D, Mölndal, Sweden
Competing Interests
This study was funded by AstraZeneca, the employer of Mikael Bjursell, Marianne Wedin, Therése Admyre, Majlis Hermansson, Gerhard Böttcher, Melker Göransson, Daniel Linden, Krister Bamberg, Jan Oscarsson, Mohammad Bohlooly-Y. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: MB MW TA GB MG DL KB MB-Y. Performed the experiments: MB MW TA MH GB MG DL KB JO MB-Y. Analyzed the data: MB TA MH GB MG DL KB JO MB-Y. Contributed reagents/materials/analysis tools: MB MW TA MH GB MG. Wrote the paper: MB DL KB JO MB-Y.